These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25694076)

  • 1. Development of HuperTacrines as non-toxic, cholinesterase inhibitors for the potential treatment of Alzheimer's disease.
    Chioua M; Pérez M; Bautista-Aguilera OM; Yañez M; López MG; Romero A; Cacabelos R; de la Bellacasa RP; Brogi S; Butini S; Borrell JI; Marco-Contelles J
    Mini Rev Med Chem; 2015; 15(8):648-58. PubMed ID: 25694076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Shao D; Zou C; Luo C; Tang X; Li Y
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids.
    Benchekroun M; Bartolini M; Egea J; Romero A; Soriano E; Pudlo M; Luzet V; Andrisano V; Jimeno ML; López MG; Wehle S; Gharbi T; Refouvelet B; de Andrés L; Herrera-Arozamena C; Monti B; Bolognesi ML; Rodríguez-Franco MI; Decker M; Marco-Contelles J; Ismaili L
    ChemMedChem; 2015 Mar; 10(3):523-39. PubMed ID: 25537267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease Therapy.
    Ramos E; Palomino-Antolín A; Bartolini M; Iriepa I; Moraleda I; Diez-Iriepa D; Samadi A; Cortina CV; Chioua M; Egea J; Romero A; Marco-Contelles J
    Molecules; 2019 Apr; 24(8):. PubMed ID: 30999586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease.
    Maalej E; Chabchoub F; Oset-Gasque MJ; Esquivias-Pérez M; González MP; Monjas L; Pérez C; de los Ríos C; Rodríguez-Franco MI; Iriepa I; Moraleda I; Chioua M; Romero A; Marco-Contelles J; Samadi A
    Eur J Med Chem; 2012 Aug; 54():750-63. PubMed ID: 22795665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
    Camps P; El Achab R ; Morral J; Muñoz-Torrero D; Badia A; Baños JE; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 2000 Nov; 43(24):4657-66. PubMed ID: 11101357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's disease.
    Cherif O; Allouche F; Chabchoub F; Chioua M; Soriano E; Yañez M; Cacabelos R; Romero A; López MG; Marco-Contelles J
    Future Med Chem; 2014; 6(17):1883-91. PubMed ID: 25495982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
    Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
    Xie SS; Wang XB; Li JY; Yang L; Kong LY
    Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontoxic and neuroprotective β-naphthotacrines for Alzheimer's disease.
    Esquivias-Pérez M; Maalej E; Romero A; Chabchoub F; Samadi A; Marco-Contelles J; Oset-Gasque MJ
    Chem Res Toxicol; 2013 Jun; 26(6):986-92. PubMed ID: 23676090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography.
    Zha X; Lamba D; Zhang L; Lou Y; Xu C; Kang D; Chen L; Xu Y; Zhang L; De Simone A; Samez S; Pesaresi A; Stojan J; Lopez MG; Egea J; Andrisano V; Bartolini M
    J Med Chem; 2016 Jan; 59(1):114-31. PubMed ID: 26632651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease.
    Oset-Gasque MJ; González MP; Pérez-Peña J; García-Font N; Romero A; del Pino J; Ramos E; Hadjipavlou-Litina D; Soriano E; Chioua M; Samadi A; Raghuvanshi DS; Singh KN; Marco-Contelles J
    Eur J Med Chem; 2014 Mar; 74():491-501. PubMed ID: 24502897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
    Badia A; Baños JE; Camps P; Contreras J; Görbig DM; Muñoz-Torrero D; Simón M; Vivas NM
    Bioorg Med Chem; 1998 Apr; 6(4):427-40. PubMed ID: 9597187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy.
    Boulebd H; Ismaili L; Bartolini M; Bouraiou A; Andrisano V; Martin H; Bonet A; Moraleda I; Iriepa I; Chioua M; Belfaitah A; Marco-Contelles J
    Molecules; 2016 Mar; 21(4):400. PubMed ID: 27023499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites.
    Gemma S; Gabellieri E; Huleatt P; Fattorusso C; Borriello M; Catalanotti B; Butini S; De Angelis M; Novellino E; Nacci V; Belinskaya T; Saxena A; Campiani G
    J Med Chem; 2006 Jun; 49(11):3421-5. PubMed ID: 16722663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
    Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
    Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids.
    Sun Y; Chen J; Chen X; Huang L; Li X
    Bioorg Med Chem; 2013 Dec; 21(23):7406-17. PubMed ID: 24128814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterase Inhibitor 6-Chlorotacrine - In Vivo Toxicological Profile and Behavioural Effects.
    Misik J; Nepovimova E; Pejchal J; Kassa J; Korabecny J; Soukup O
    Curr Alzheimer Res; 2018; 15(6):552-560. PubMed ID: 29231138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.